Search

Allograft Inflammatory Factor‐1 (AIF1) is a cytoplasmic scaffold protein that contains Ca2+ binding EF‐hand and PDZ interaction domains important for mediating intracellular signaling complexes in immune cells. The protein plays a dominant role in both macrophage‐ and dendritic cell (DC)‐mediated inflammatory responses. This study now reports that AIF1 expression in DC is important in directing CD8+ T cell effector responses. Silencing AIF1 expression in murine CD11c+ DC suppressed antigen‐specific CD8+ T cell activation, marked by reduced CXCR3, IFNγ and Granzyme B expression, and restrained proliferation. These primed CD8+ T cells had impaired cytotoxic killing of target cells in vitro. In turn, studies identified that AIF1 silencing in DC robustly expanded IL‐10 producing CD8+ CD122+ PD‐1+ regulatory T cells that suppressed neighboring immune effector responses through both IL‐10 and PD‐1‐dependent mechanisms. In vivo studies recapitulated bystander suppression of antigen‐responsive CD4+ T cells by the CD8+ Tregs expanded from the AIF1 silenced DC. These studies further demonstrate that AIF1 expression in DC serves as a potent governor of cognate T cell responses and present a novel target for engineering tolerogenic DC‐based immunotherapies. Adaptive immune responses are impaired in CD8+ T cells primed by DC silenced for AIF1. [ABSTRACT FROM AUTHOR]

Allograft Inflammatory Factor-1 (AIF1) is a cytoplasmic scaffold protein that contains Ca 2+ binding EF-hand and PDZ interaction domains important for mediating intracellular signaling complexes in immune cells. The protein plays a dominant role in both macrophage- and dendritic cell (DC)-mediated inflammatory responses. This study now reports that AIF1 expression in DC is important in directing CD8 + T cell effector responses. Silencing AIF1 expression in murine CD11c + DC suppressed antigen-specific CD8 + T cell activation, marked by reduced CXCR3, IFNγ and Granzyme B expression, and restrained proliferation. These primed CD8 + T cells had impaired cytotoxic killing of target cells in vitro. In turn, studies identified that AIF1 silencing in DC robustly expanded IL-10 producing CD8 + CD122 + PD-1 + regulatory T cells that suppressed neighboring immune effector responses through both IL-10 and PD-1-dependent mechanisms. In vivo studies recapitulated bystander suppression of antigen-responsive CD4 + T cells by the CD8 + Tregs expanded from the AIF1 silenced DC. These studies further demonstrate that AIF1 expression in DC serves as a potent governor of cognate T cell responses and present a novel target for engineering tolerogenic DC-based immunotherapies., (©2018 Society for Leukocyte Biology.)